Managing Chemotherapy-Related Anxiety in a 70-Year-Old Patient
For anxiety that occurs specifically during chemotherapy in older adults, implement structured screening using PROMIS Anxiety-4 (threshold ≥11) and provide immediate non-pharmacologic interventions including music therapy during infusions, combined with referral to psycho-oncology services for counseling and consideration of pharmacologic therapy if symptoms are severe. 1
Initial Assessment and Screening
- Screen systematically using PROMIS Anxiety 4-item scale during chemotherapy visits, with a raw score ≥11 indicating clinically significant anxiety requiring intervention 1
- Assess whether anxiety represents situational distress tied to chemotherapy administration versus broader psychological distress 1
- Evaluate suicide risk and elder abuse if appropriate, particularly given the vulnerability of older adults 1
First-Line Non-Pharmacologic Interventions
Music Therapy (Strongest Evidence for Chemotherapy-Specific Anxiety)
- Implement 30-minute passive music listening during each chemotherapy infusion cycle, which significantly reduces both state and trait anxiety (effect size η²=0.808 for state anxiety, p<0.001) 2
- Music intervention is particularly effective for patients with high baseline anxiety levels and provides immediate anxiety reduction during the chemotherapy session 2, 3
- This approach is low-cost, non-invasive, and easily implemented in outpatient chemotherapy units 2
Structured Exercise Program
- Initiate a home-based walking and resistance training program for the duration of chemotherapy, as this produces clinically significant improvements in anxiety, particularly among older adults with worse baseline symptoms 4
- The Exercise for Cancer Patients (EXCAP) program shows statistically significant reductions in STAI scores (p=0.001) and improvements in emotional well-being (p=0.048) over 6 weeks 4
Referral and Escalation Strategy
Psycho-Oncology Referral
- Refer to psycho-oncology services (social work, clinical psychology) for counseling as the primary intervention for moderate-to-severe anxiety 1
- Consider relaxation training and systematic desensitization techniques, which are effective for chemotherapy-related phobic anxiety and conditioned anxiety responses 5
- Progressive muscle relaxation may be particularly beneficial for patients with distraction-oriented coping styles 6
Pharmacologic Therapy Consideration
- Consider initiating pharmacologic therapy in conjunction with the primary care physician for patients with severe symptoms (PROMIS score ≥11) or those not responding adequately to non-pharmacologic interventions 1
- Refer to psychiatry if symptoms are severe or if existing medications are inadequate 1
Additional Supportive Measures
- Assess and optimize social support systems, as inadequate instrumental or emotional support (MOS Social Support scale showing "none, a little, or some of the time") compounds anxiety during chemotherapy 1
- Provide linkage to community resources including support groups and local/national buddy programs 1
- Consider spiritual counseling or chaplaincy services as adjunctive support 1
Critical Context for Older Adults
- Use aggressive antiemetic therapy to prevent conditioned nausea responses that can worsen anticipatory anxiety before subsequent chemotherapy cycles 1
- Monitor for the co-occurrence of depression, as patients with both moderate-to-high anxiety AND depression experience significantly worse symptom burden and quality of life outcomes during chemotherapy 7
- Be aware that chemotherapy itself increases rates of psychological morbidity, making proactive screening and early intervention essential 8
Common Pitfalls to Avoid
- Do not delay intervention until anxiety becomes severe—implement music therapy and screening from the first chemotherapy cycle 2
- Avoid assuming anxiety will resolve after chemotherapy completion; some patients develop persistent conditioned responses requiring behavioral interventions 5
- Do not overlook the "dose-response" relationship between anxiety severity and overall symptom burden—patients with higher anxiety report worse fatigue, pain, sleep disturbance, and cognitive function 7